Gene: SAXO2
Official Full Name: stabilizer of axonemal microtubules 2provided by HGNC
Gene Summary: Predicted to enable microtubule binding activity. Predicted to be active in microtubule cytoskeleton; nucleus; and sperm flagellum. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14351 | SAXO2 Knockout cell line (HeLa) | Human | SAXO2 | 1:3~1:6 | Negative | Online Inquiry |
KO14352 | SAXO2 Knockout cell line (HCT 116) | Human | SAXO2 | 1:2~1:4 | Negative | Online Inquiry |
KO14353 | SAXO2 Knockout cell line (HEK293) | Human | SAXO2 | 1:3~1:6 | Negative | Online Inquiry |
KO14354 | SAXO2 Knockout cell line (A549) | Human | SAXO2 | 1:3~1:4 | Negative | Online Inquiry |
SAXO2 Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology that enables researchers to study gene function and assess the biological implications of gene deletions. These engineered cell lines are created using CRISPR-Cas9 technology, allowing for precise and targeted disruption of the SAXO2 gene, which plays a critical role in cellular processes such as metabolism, proliferation, and differentiation.
The primary function of SAXO2 Gene Knockout Cell Lines is to facilitate the investigation of gene-specific roles by enabling researchers to observe the resultant phenotypic and biochemical changes following gene inactivation. By eliminating SAXO2 expression, scientists can decode the gene's influence on various cellular pathways and identify downstream effects, thus providing insights into its involvement in disease mechanisms or therapeutic responses.
From a scientific perspective, SAXO2 Gene Knockout Cell Lines are invaluable in both basic and applied research contexts. Their use extends to gene function studies, drug screening processes, and the development of novel therapeutics, particularly in understanding conditions linked to SAXO2 dysregulation, such as metabolic disorders and certain cancers.
What sets SAXO2 Gene Knockout Cell Lines apart from existing alternatives is their high specificity, reproducibility, and the streamlined character of the knockout process. Unlike traditional methods of gene disruption, the CRISPR-Cas9 approach ensures minimal off-target effects, thus safeguarding the reliability of experimental outcomes. Additionally, these cell lines are rigorously validated, providing a robust tool for researchers looking to accelerate their discoveries.
For researchers and clinicians, the SAXO2 Gene Knockout Cell Lines present an exceptional opportunity to advance their work with confidence in the product’s reliability and scientific rigor. By utilizing these cell lines, users can bridge the gap between gene function and disease etiology, paving the way for innovative approaches to treatment.
Our company is committed to delivering high-quality biological products, and our expertise in gene editing and cell line development ensures that the SAXO2 Gene Knockout Cell Lines meet the highest standards of performance and reliability, empowering researchers to make meaningful advancements in their field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.